Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Concentrix Corp (NASDAQ: CNXC) closed at $54.99 in the last session, down -1.10% from day before closing price of $55.6. In other words, the price has decreased by -$1.10 from its previous closing price. On the day, 1.27 million shares were traded. CNXC stock price reached its highest trading level at $55.52 during the session, while it also had its lowest trading level at $54.12.
Ratios:
We take a closer look at CNXC’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.48 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.15. For the most recent quarter (mrq), Quick Ratio is recorded 1.61 and its Current Ratio is at 1.61. In the meantime, Its Debt-to-Equity ratio is 1.35 whereas as Long-Term Debt/Eq ratio is at 1.28.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Barrington Research on March 24, 2025, Reiterated its Outperform rating but revised its target price to $54 from $70 previously.
On October 03, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $70.
BofA Securities Upgraded its Underperform to Neutral on August 28, 2024, whereas the target price for the stock was revised from $65 to $85.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 29 ’25 when Twomey Cormac J sold 500 shares for $50.25 per share. The transaction valued at 25,125 led to the insider holds 36,630 shares of the business.
CORMAC TWOMEY bought 500 shares of CNXC for $25,125 on Aug 29 ’25. On Jul 30 ’25, another insider, Twomey Cormac J, who serves as the EVP, Global Ops & Delivery of the company, sold 500 shares for $57.91 each. As a result, the insider received 28,955 and left with 37,130 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNXC now has a Market Capitalization of 3465751552 and an Enterprise Value of 8940255232. As of this moment, Concentrix’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.10, and their Forward P/E ratio for the next fiscal year is 4.41. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.29. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.36 while its Price-to-Book (P/B) ratio in mrq is 0.81. Its current Enterprise Value per Revenue stands at 0.929 whereas that against EBITDA is 6.337.
Stock Price History:
The Beta on a monthly basis for CNXC is 0.59, which has changed by 0.06652439 over the last 52 weeks, in comparison to a change of 0.15101504 over the same period for the S&P500. Over the past 52 weeks, CNXC has reached a high of $66.00, while it has fallen to a 52-week low of $36.28. The 50-Day Moving Average of the stock is 4.19%, while the 200-Day Moving Average is calculated to be 8.33%.
Shares Statistics:
According to the various share statistics, CNXC traded on average about 729.32K shares per day over the past 3-months and 842620 shares per day over the past 10 days. A total of 62.93M shares are outstanding, with a floating share count of 44.65M. Insiders hold about 29.15% of the company’s shares, while institutions hold 81.99% stake in the company. Shares short for CNXC as of 1756425600 were 7030374 with a Short Ratio of 10.50, compared to 1753920000 on 7060856. Therefore, it implies a Short% of Shares Outstanding of 7030374 and a Short% of Float of 13.420000000000002.
Earnings Estimates
Investors are keenly observing as 5.0 analysts analyze and rate the current performance of Concentrix Corp (CNXC) in the stock market.The consensus estimate for the next quarter is $3.02, with high estimates of $3.09 and low estimates of $2.94.
Analysts are recommending an EPS of between $11.86 and $11.63 for the fiscal current year, implying an average EPS of $11.69. EPS for the following year is $12.46, with 6.0 analysts recommending between $13.07 and $11.88.
Revenue Estimates
According to 4 analysts, the current quarter’s revenue is expected to be $2.53B. It ranges from a high estimate of $2.55B to a low estimate of $2.52B. As of the current estimate, Concentrix Corp’s year-ago sales were $2.45BFor the next quarter, 4 analysts are estimating revenue of $2.48B. There is a high estimate of $2.51B for the next quarter, whereas the lowest estimate is $2.46B.
A total of 5 analysts have provided revenue estimates for CNXC’s current fiscal year. The highest revenue estimate was $9.81B, while the lowest revenue estimate was $9.77B, resulting in an average revenue estimate of $9.78B. In the same quarter a year ago, actual revenue was $9.62BBased on 5 analysts’ estimates, the company’s revenue will be $10.08B in the next fiscal year. The high estimate is $10.26B and the low estimate is $9.95B.
